Production (Stage)
Innovation1 Biotech Inc.
IVBT
$0.005
$0.00482,400.00%
OTC PK
| 02/29/2024 | 11/30/2023 | 08/31/2023 | 05/31/2023 | 02/28/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 150.00K | 155.60K | 178.40K | 203.40K | 256.00K |
| Depreciation & Amortization | 300.00 | 300.00 | 300.00 | 300.00 | 300.00 |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 150.30K | 155.80K | 178.70K | 203.60K | 256.30K |
| Operating Income | -150.30K | -155.80K | -178.70K | -203.60K | -256.30K |
| Income Before Tax | -289.70K | -255.20K | -4.45M | -298.90K | -603.40K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -289.70K | -255.20K | -4.45M | -298.90K | -603.40K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -289.70K | -255.20K | -4.45M | -298.90K | -603.40K |
| EBIT | -150.30K | -155.80K | -178.70K | -203.60K | -256.30K |
| EBITDA | -150.00K | -155.60K | -178.40K | -203.40K | -256.00K |
| EPS Basic | -0.02 | -0.02 | -0.23 | -0.03 | -0.40 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.04 | -0.01 | -0.01 |
| EPS Diluted | -0.02 | -0.02 | -0.23 | -0.03 | -0.40 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.04 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 22.47M | 21.12M | 20.47M | 20.32M | 20.02M |
| Average Diluted Shares Outstanding | 22.47M | 21.12M | 20.47M | 20.32M | 20.02M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |